52N-22641-19509
3 vaccinations
3 coded responses
32 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 603 / IL
- Registered
- 2021-01-04
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-04
Registered in v-safe
-
2021-01-04
Dose 1 — Pfizer-BioNTech
-
2021-01-04
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-01-05
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-01-06
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
-
2021-01-18
Survey response — day 14, dose 1MedDRA: Constipation, Haemorrhoids, Rectal haemorrhage — Feeling: GoodFree text: Rectal bleeding for three consecutive days, which may be due to constipation and/or hemorrhoidsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-25
Dose 2 — Pfizer-BioNTech
- 2021-01-25
-
2021-01-26
Survey response — days 1–6 daily, dose 2MedDRA: Dyspepsia — Feeling: Poor · Site: Pain · Nausea · Be unable to do your normal daily activitiesFree text: Indigestion and heartburnMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-27
- 2021-01-28
- 2021-01-30
- 2021-01-31
- 2021-02-03
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-03-01
-
2021-03-08
Survey response — day 42, dose 2MedDRA: Diarrhoea, Fatigue, Headache, Nausea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Diarrhea, nausea, headache, fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-26
- 2021-07-26
-
2021-09-25
Dose 3 — Pfizer-BioNTech
-
2021-09-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-10-30
- 2021-11-06
- 2021-12-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Pfizer-BioNTech | |
| 2 | 2021-01-25 | Pfizer-BioNTech | |
| 3 | 2021-09-25 | Pfizer-BioNTech | No |
Free text
Release 2 — day 14, dose 1
Symptoms: Rectal bleeding for three consecutive days, which may be due to constipation and/or hemorrhoids
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Indigestion and heartburn
Release 5 — day 42, dose 2
Symptoms: Diarrhea, nausea, headache, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Constipation | ✓ | ✓ | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Haemorrhoids | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Rectal haemorrhage | ✓ | ✓ | ✓ |
| SRO | Dyspepsia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release